These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2168573)

  • 21. Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy.
    Blakely CM; Stoddard AJ; Belka GK; Dugan KD; Notarfrancesco KL; Moody SE; D'Cruz CM; Chodosh LA
    Cancer Res; 2006 Jun; 66(12):6421-31. PubMed ID: 16778221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor effect of the antiestrogen, tamoxifen, ona pregnancy-dependent mouse mammary tumor (TPDMT-4).
    Matsuzawa A; Mizuno Y; Yamamoto T
    Cancer Res; 1981 Jan; 41(1):316-24. PubMed ID: 7448771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ovariectomy on hormone receptors and growth of N-nitrosomethylurea-induced mammary tumors in the rat.
    Arafah BM; Gullino PM; Manni A; Pearson OH
    Cancer Res; 1980 Dec; 40(12):4628-30. PubMed ID: 6254648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
    Sylvester PW; Ip C; Ip MM
    Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between estrogens, prolactin, and growth hormone on the growth of N-nitrosomethylurea-induced rat mammary tumors.
    Rose DP; Gottardis M
    Anticancer Res; 1985; 5(4):397-402. PubMed ID: 4037735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
    Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
    Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors.
    Kiss R; de Launoit Y; Danguy A; Paridaens R; Pasteels JL
    Cancer Res; 1989 Jun; 49(11):2945-51. PubMed ID: 2720654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormones and neoplasia.
    Forrest AP
    J Clin Pathol Suppl (R Coll Pathol); 1974; 7():65-71. PubMed ID: 4364584
    [No Abstract]   [Full Text] [Related]  

  • 29. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract.
    Freudenstein J; Dasenbrock C; Nisslein T
    Cancer Res; 2002 Jun; 62(12):3448-52. PubMed ID: 12067987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential benefits of estrogens and progestogens on breast cancer.
    Schneider HP; Jackisch C
    Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
    Manni A; Rainieri J; Arafah BM; Finegan HM; Pearson OH
    Cancer Res; 1982 Sep; 42(9):3492-5. PubMed ID: 6286107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of progesterone, ovariectomy and adrenalectomy on mammary tumours induced by 7,12-dimethylbenz(a)anthracene in Sprague-Dawley rats.
    Jabara AG; Harcourt AG
    Pathology; 1971 Jul; 3(3):209-14. PubMed ID: 5115391
    [No Abstract]   [Full Text] [Related]  

  • 33. Mammary developmental fate and breast cancer risk.
    Medina D
    Endocr Relat Cancer; 2005 Sep; 12(3):483-95. PubMed ID: 16172188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of ovariectomy and retinyl acetate on the growth of established 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat.
    Gandilhon P; Melancon R; Djiane J; Kelly PA
    J Natl Cancer Inst; 1982 Aug; 69(2):447-51. PubMed ID: 6287078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causes of age-dependency of mammary tumour induction by carcinogens in rats.
    Nagasawa H
    Biomedicine; 1981 Feb; 34(1):9-11. PubMed ID: 6784782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effects of progesterone and tamoxifen in estrogen-induced mammary carcinogenesis in ovariectomized W/Fu rats.
    Inoh A; Kamiya K; Fujii Y; Yokoro K
    Jpn J Cancer Res; 1985 Aug; 76(8):699-704. PubMed ID: 3930447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
    Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
    In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation.
    Gattelli A; Cirio MC; Quaglino A; Schere-Levy C; Martinez N; Binaghi M; Meiss RP; Castilla LH; Kordon EC
    Cancer Res; 2004 Aug; 64(15):5193-9. PubMed ID: 15289324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings: Oestrogen receptor content and hormone-responsive growth of mouse mammary tumours.
    Sluyser M; Van Nie R
    J Endocrinol; 1975 Mar; 64(3):24P-25P. PubMed ID: 166126
    [No Abstract]   [Full Text] [Related]  

  • 40. Endocrinology in cancer of the breast. Status and prospects.
    Brennan MJ
    Am J Clin Pathol; 1975 Dec; 64(6):797-809. PubMed ID: 173180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.